Hansen, M, Pedersen, AG (1986) Tumor markers in patients with lung cancer. Chest 89: pp. 2195-2245Hansen M, Pedersen AG. Tumor markers in patients with lung cancer. Chest 1986; 89(Suppl):219s-224s.Hansen, H. & Pedersen, A. (1986), `Tumor markers in patients with lung cancer', ...
In conclusion, serum CYFRA 21-1 and TPA levels were consistently elevated in patients with malignant mesothelioma, but neither parameter is likely to be useful in distinguishing malignant mesothelioma from adenocarcinoma with pleural involvement. Serum HA and CEA levels remain useful markers for ...
lysates. Supplementary Figure8fshow that while whole tumor lysate (mEERLEphrinB1) was positive for β-III tubulin, Tau and TRPV1, whole cell lysates from mEERL parental cells and its derivative cell lines were negative for these neuronal markers indicating that the cancer cells obtain nerves ...
Secufferlein, T, Adler, G What can be Expected from Tumor Markers in Pancreatic Cancer. In: Dominguez-Munoz, JE eds. (2005) Clinical pancreatology for practicing gastroenterologist. Blackwell, Malden, pp. 377-382Secufferlein T, Adler G. What can be Expected from Tumor Markers in Pancreatic...
Plasticity of disseminating cancer cells in patients with epithelial malignancies. Cancer Metastasis Rev. 31, 673–687 (2012). Article CAS PubMed Google Scholar Yokobori, T. et al. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is ...
(80%) because of increased levels of serum tumor markers. No disease recurrence was detected by routine complete blood counts or automated chemistry studies alone. Our experience indicates that an effective follow-up regimen for patients with early breast cancer may include careful history-taking, ...
BACKGROUND: About 5-10% of cancer patients suffer from cancer of unknownprimary (CUP). Sophisticated diagnostic techniques have not improved diagnostic efficacy for these patients.The aim of our analysis was to evaluate serum levels of four tumor markers and to relate them to thehistology, number...
CEAtoscreenforcoloncancer,orrelapse? Elevatedinsmokers Elevatedinothercancersandbenigndisease Normalin85%ofpatientswithpoorlydifferentiatedcanceratpresentation Onlyasmallpercentagehaveresectabledisease Isthepatientfitforpartialhepatectomy? TumorMarkers–somekeyfacts: Lackofspecificity Cancerheterogeneity Falsenegatives Be...
[5] Tie J, Cohen JD, Wang Y, et al. Circulating tumor DNA analyses as markers of recurrence risk and benefit of adjuvant therapy for stage III colon cancer. JAMA Oncol. 2019; 5(12): 1710-1717.[6] Chan HT, Nagayama S, Otaki M, et al. Tumor-informed or tumor-agnostic circulating ...
In this presentation, individual markers which have been used in managing patients with lung cancer will be discussed as will attempts to employ in these patients multivariate analysis of a group of markers. Carcinoembryonic Antigen (CEA) CEA has been widely used in patients with lung cancer. In...